Mead Christopher E

Gallagher VP Mead sells 4,000 shares at $227.12; stock now -37.6% from 52-week high and -9.8% in 30 days.

Vice President Christopher E. Mead sold 4,000 shares on 2026-03-05 at $227.12, reducing his holdings by 17.2% to 19,305 shares totaling $908,472.00 in proceeds. The transaction occurs as AJG trades at $217.78, down 37.6% from its 52-week high of $348.77 and down 9.8% over the past 30 days, suggesting execution during a period of material stock weakness. Mead's prior five trades at AJG show mixed timing outcomes: only 1 of 4 completed sales were well-timed at the 90-day mark, indicating inconsistent predictive signal from his trading pattern at this ticker. The company's fundamentals remain substantive with $3.4B in latest quarterly revenue, 20.7% annual growth, and a $56.0B market cap, though the elevated P/E of 34.30 may reflect valuation compression from recent price action.

Vice President Mead Christopher E sold 4,000 shares of AJG at $258.11 on 2025-12-23; stock at $263.14, down 24.6% from 52-week high of $348.77.

Christopher E sold 4,000 shares (-19.1% of his pre-transaction holdings of 20,938 shares) at $258.11 on 2025-12-23, with Arthur J. Gallagher trading at $263.14 currently, down 24.6% from its 52-week high of $348.77. His cross-ticker track record shows a well-timed rate of 20.00% on 5 prior sells with an average 90-day return of +4.7%, but his prior trades at AJG specifically have been poorly timed at the 90-day horizon: only 1 of 5 prior sells showed negative 90-day returns, with the most recent sale on 2025-02-03 followed by a 90-day return of +9.4%. The company reports strong fundamentals with annual revenue growth of +14.7%, $3.4B in revenue, and $272.7M net income (P/E 42.17), though the recent price action suggests a significant drawdown from peak valuation.

VP Christopher E. Mead sells 2,900 AJG shares at $302.61; holds 14,673 post-sale as stock near 52-week high.

Christopher E. Mead, Vice President, sold 2,900 shares (16.5% of pre-transaction holdings) at $302.61, reducing his position from 17,573 to 14,673 shares. The sale occurred when AJG was at +0.0% from its 52-week high of $316.30, during a period of significant recent appreciation (+14.4% over 30 days, +8.9% over 90 days). Across his cross-ticker trading history, Mead's prior sells showed a 90-day well-timed rate of 25.00%, and his prior four sales at AJG specifically achieved only 1 well-timed outcome at the 90-day mark. The current valuation reflects a P/E of 59.23 with the company reporting strong fundamentals (annual revenue growth of +17.8%, $2.8B quarterly revenue, $312.6M net income). This sale represents a standard reduction of his AJG stake near peak valuations and recent highs, without clear pattern evidence of superior timing at this ticker.

VP Mead sells 2,800 AJG shares at $287.00 on 2024-10-28; stock now -5.0% from 52-week high, insider retains 14,673 shares post-sale.

Mead Christopher E, Vice President, sold 2,800 shares at $287.00, executing a -16.0% reduction from his pre-transaction holdings of 17,473 shares. The sale occurred near the upper end of the stock's 52-week range ($220.11–$299.55), with the current price at $284.48 positioned -5.0% from the 52-week high. Reviewing his cross-ticker track record, Mead's prior open-market sells achieved a 33.33% well-timed rate (1 of 3 sells) at the 90-day mark, suggesting mixed execution timing discipline across his portfolio. At AJG specifically, his prior three sales (2024-02-14, 2023-10-31, 2023-08-25) showed an average 90-day return of +4.6%, with only 1 of 3 classified as well-timed, indicating that this ticker's price has often risen after his prior exits. The current sale removes a material block of shares (16.0%) while retaining substantial AJG exposure of 14,673 shares post-transaction.